Advanced Medical Solutions

Advanced Medical Solutions (AMS), headquartered in GB and operating within the Health and social work services (85) industry, has reported significant carbon emissions across its operations.

For the year 2025, AMS reported total emissions of approximately 80.4 million kg CO2e. This breaks down into Scope 1 emissions of about 2.76 million kg CO2e, Scope 2 emissions of approximately 5.01 million kg CO2e, and substantial Scope 3 emissions totalling around 71.6 million kg CO2e.

Looking back, in 2024, AMS's total emissions were approximately 106.6 million kg CO2e. Scope 1 accounted for about 2.41 million kg CO2e, Scope 2 for approximately 5.25 million kg CO2e, and Scope 3 emissions were around 98.9 million kg CO2e. In 2023, total emissions were approximately 52.0 million kg CO2e, with Scope 1 at about 1.34 million kg CO2e, Scope 2 at approximately 1.34 million kg CO2e, and Scope 3 at around 50.5 million kg CO2e. For 2022, total emissions were approximately 2.43 million kg CO2e, comprising about 1.50 million kg CO2e for Scope 1 and 1.20 million kg CO2e for Scope 2. Scope 3 emissions in 2022 were approximately 49.0 million kg CO2e.

AMS is actively pursuing climate commitments to reduce its environmental impact. The company has set a long-term goal to achieve Net Zero across all scopes by 2045, using a 2021 baseline. In the near term, AMS aims for a 42% absolute reduction in Scope 1 and 2 Greenhouse Gas (GHG) emissions by 2030, also from a 2021 baseline. A more recent commitment details a 42% reduction in Scope 1 and 2 emissions by 2030 from a FY24 baseline (location-based), alongside a 90% absolute reduction in Scope 1 and 2 emissions by 2045 from the same FY24 baseline. Furthermore, AMS is targeting Net-Zero Scope 3 emissions by FY45 from an FY24 base year. A specific Scope 3 target includes a 30% absolute reduction in Scope 3 Category 12 (End-of-Life Treatment of Sold Products) GHG emissions per tonne of product sold by 2033, from an FY24 base year.

The company's approach to climate action is guided by its 'Pathway to Net Zero' project, initiated in 2022. AMS has also committed to maintaining zero Scope 1 emissions through FY2030, with targets aligned with keeping warming to 1.5°C, as validated by the Science Based Targets initiative (SBTi). These SBTi targets, set against a FY2023 base year, include a 42% reduction in absolute Scope 2 GHG emissions by FY2030. AMS also commits to measuring and reducing its Scope 3 emissions.